These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 25542083)
1. Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas. Zanotto-Filho A; Braganhol E; Klafke K; Figueiró F; Terra SR; Paludo FJ; Morrone M; Bristot IJ; Battastini AM; Forcelini CM; Bishop AJR; Gelain DP; Moreira JCF Cancer Lett; 2015 Mar; 358(2):220-231. PubMed ID: 25542083 [TBL] [Abstract][Full Text] [Related]
2. The Synergistic Combination of Curcumin and Polydatin Improves Temozolomide Efficacy on Glioblastoma Cells. Serafino A; Krasnowska EK; Romanò S; De Gregorio A; Colone M; Dupuis ML; Bonucci M; Ravagnan G; Stringaro A; Fuggetta MP Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408901 [TBL] [Abstract][Full Text] [Related]
3. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381 [TBL] [Abstract][Full Text] [Related]
4. Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma. Wu H; Liu Q; Cai T; Chen YD; Wang ZF Mol Med Rep; 2015 Oct; 12(4):5461-6. PubMed ID: 26239619 [TBL] [Abstract][Full Text] [Related]
5. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival. Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808 [TBL] [Abstract][Full Text] [Related]
6. Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways. Bagherian A; Mardani R; Roudi B; Taghizadeh M; Banfshe HR; Ghaderi A; Davoodvandi A; Shamollaghamsari S; Hamblin MR; Mirzaei H J Mol Neurosci; 2020 Oct; 70(10):1471-1483. PubMed ID: 32666415 [TBL] [Abstract][Full Text] [Related]
7. Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition. Zhang P; Sun S; Li N; Ho ASW; Kiang KMY; Zhang X; Cheng YS; Poon MW; Lee D; Pu JKS; Leung GKK J Neurooncol; 2017 May; 132(3):393-400. PubMed ID: 28293765 [TBL] [Abstract][Full Text] [Related]
8. Targeting autophagy to sensitive glioma to temozolomide treatment. Yan Y; Xu Z; Dai S; Qian L; Sun L; Gong Z J Exp Clin Cancer Res; 2016 Feb; 35():23. PubMed ID: 26830677 [TBL] [Abstract][Full Text] [Related]
9. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo. Chakrabarti M; Ray SK Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation. Li H; Liu Y; Jiao Y; Guo A; Xu X; Qu X; Wang S; Zhao J; Li Y; Cao Y Oncol Rep; 2016 Jan; 35(1):343-51. PubMed ID: 26498391 [TBL] [Abstract][Full Text] [Related]
11. Autophagy inhibition potentiates SAHA‑mediated apoptosis in glioblastoma cells by accumulation of damaged mitochondria. Lohitesh K; Saini H; Srivastava A; Mukherjee S; Roy A; Chowdhury R Oncol Rep; 2018 Jun; 39(6):2787-2796. PubMed ID: 29658588 [TBL] [Abstract][Full Text] [Related]
12. Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells. Palumbo S; Tini P; Toscano M; Allavena G; Angeletti F; Manai F; Miracco C; Comincini S; Pirtoli L J Cell Physiol; 2014 Nov; 229(11):1863-73. PubMed ID: 24691646 [TBL] [Abstract][Full Text] [Related]
13. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells. Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608 [TBL] [Abstract][Full Text] [Related]
14. Late autophagy inhibitor chloroquine improves efficacy of the histone deacetylase inhibitor SAHA and temozolomide in gliomas. Gonçalves RM; Agnes JP; Delgobo M; de Souza PO; Thomé MP; Heimfarth L; Lenz G; Moreira JCF; Zanotto-Filho A Biochem Pharmacol; 2019 May; 163():440-450. PubMed ID: 30878553 [TBL] [Abstract][Full Text] [Related]
15. The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells. Lee SW; Kim HK; Lee NH; Yi HY; Kim HS; Hong SH; Hong YK; Joe YA Cancer Lett; 2015 May; 360(2):195-204. PubMed ID: 25681668 [TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide. Quann K; Gonzales DM; Mercier I; Wang C; Sotgia F; Pestell RG; Lisanti MP; Jasmin JF Cell Cycle; 2013 May; 12(10):1510-20. PubMed ID: 23598719 [TBL] [Abstract][Full Text] [Related]
18. BC3EE2,9B, a synthetic carbazole derivative, upregulates autophagy and synergistically sensitizes human GBM8901 glioblastoma cells to temozolomide. Chen CM; Syu JP; Way TD; Huang LJ; Kuo SC; Lin CT; Lin CL Int J Mol Med; 2015 Nov; 36(5):1244-52. PubMed ID: 26329365 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224 [TBL] [Abstract][Full Text] [Related]
20. Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells. Banelli B; Daga A; Forlani A; Allemanni G; Marubbi D; Pistillo MP; Profumo A; Romani M Oncotarget; 2017 May; 8(21):34896-34910. PubMed ID: 28432280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]